CCS
INGN icon

Crosspoint Capital Strategies’s Inogen INGN Stock Holding History

Crosspoint Capital Strategies’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-158
Closed -$5K – 631
2015
Q1 		$5K Buy
+158
New +$5.1K ﹤0.01% 452

Other funds holding INGN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Crosspoint Capital Strategies's INGN Position: Q2 2015 in Review

Crosspoint Capital Strategies sold out of Inogen (INGN) in Q2 2015, closing a stake of 158 shares — an estimated $5K sold.

Crosspoint Capital Strategies first reported a position in INGN in Q1 2015 and held it in 1 quarter. The position peaked at $5K in Q1 2015. 131 funds tracked by Wall St. Rank hold INGN as of Q2 2015.

  • Crosspoint Capital Strategies reported no remaining Inogen position as of Q2 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 158 Inogen shares in Q2 2015, an estimated $5K.
  • Crosspoint Capital Strategies first reported a position in Inogen in Q1 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Inogen position peaked at $5K in Q1 2015.
  • 131 funds tracked by Wall St. Rank held Inogen as of Q2 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2015, filed 24 Aug 2015.